Melanoma Institute Australia
Clinical trials sponsored by Melanoma Institute Australia, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug combo shows promise in shrinking skin cancer before surgery Results expected Sep 2026 (estimated)
- New immunotherapy combo aims to stop merkel cell cancer return Results expected Dec 2026 (estimated)
- Can a simple test predict who will beat skin cancer with immunotherapy? Results expected Jun 2027 (estimated)
-
Melanoma patients get drug combo before surgery in new trial
Disease control CompletedThis phase II trial tests whether giving two targeted drugs (dabrafenib and trametinib) before and after surgery can improve outcomes for people with stage IIIB-C melanoma that has a BRAF V600 mutation. 35 participants will take the drugs for 12 weeks before surgery, then continu…
Phase 2 • Sponsor: Melanoma Institute Australia • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New study matches melanoma patients to drugs based on their Tumor's genes
Disease control CompletedThis study looked at 216 people with advanced melanoma that had stopped responding to standard treatments. Researchers tested each person's tumor for specific genetic changes and then gave them a drug designed to target that change. The goal was to see if this personalized approa…
Phase 2 • Sponsor: Melanoma Institute Australia • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Pill before surgery may reduce scarring for skin cancer patients
Disease control CompletedThis study tested whether taking a daily pill called sonidegib for 12 weeks could shrink basal cell carcinomas in cosmetically sensitive areas like the face. The goal was to make surgery less invasive, reduce scarring, or even avoid surgery altogether by using only a topical crea…
Phase 2 • Sponsor: Melanoma Institute Australia • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC